Výsledky vyhledávání - "Kate J Young"

Akademický článek

Pretransplant Cognitive Function and Kidney Transplant Outcomes: A Prospective Cohort Study

Autor: Aditi Gupta, Michael J. Grasing, Kate J. Young, Robert N. Montgomery, Daniel J. Murillo, Diane M. Cibrik

Publikováno v: Kidney Medicine, Vol 6, Iss 9, Pp 100872- (2024)

Background & Hypothesis: Cognitive impairment is common in patients being evaluated for a kidney transplant (KT). The association between pretransplant cognitive function and posttransplant outcomes is unclear. Study Design: We performed a prospectiv

Externí odkaz: https://doaj.org/article/5b2c706cd22c4fdfb6772329e1321573

Zobrazit plný text záznamu

Statistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker studies

Autor: Leonidas E Bantis, Kate J Young, John V Tsimikas, Brian R Mosier, Byron Gajewski, Sharon Yeatts, Renee L Martin, William Barsan, Robert Silbergleit, Gaylan Rockswold, Frederick K Korley

Publikováno v: Res Methods Med Health Sci

Studies that investigate the performance of prognostic and predictive biomarkers are commonplace in medicine. Evaluating the performance of biomarkers is challenging in traumatic brain injury (TBI) and other conditions when both the time factor (i.e.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7cfb0ea16548e12920216b4e6991782
https://doi.org/10.1177/26320843221141056

Zobrazit plný text záznamu

First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive Function

Autor: Jamie S. Myers, Adam C. Parks, Jonathan D. Mahnken, Kate J. Young, Harsh B. Pathak, Rajni V. Puri, Amber Unrein, Phyllis Switzer, Yazan Abdulateef, Samantha Sullivan, John F. Walker, David Streeter, Jeffrey M. Burns

Publikováno v: Cancers; Volume 15; Issue 5; Pages: 1615

Approximately 40% of patients with cancer are eligible for check-point inhibitor (CPI) therapy. Little research has examined the potential cognitive impact of CPIs. First-line CPI therapy offers a unique research opportunity without chemotherapy-rela

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6204337c17b9b46a360df42e157e81
https://doi.org/10.3390/cancers15051615

Zobrazit plný text záznamu

Plný text ve formátu HTML

Epidermal Growth Factor Receptor Inhibitor Treatment Timing does not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective Study

Autor: Braden M, Johnson, Tony A, Pham, Kate J, Young, Leonidas E, Bantis, Weijing, Sun, Anup, Kasi

Publikováno v: Kansas journal of medicine. 15

Colon cancer impacts the lives of Kansans and those across the United States. Epidermal growth factor receptor (EGFR) inhibitors, such as panitumumab and cetuximab, have gained popularity as first-line treatment for stage 4 colon cancer despite their

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a8e70daaf43449cf4c2825f1cfb0e373
https://pubmed.ncbi.nlm.nih.gov/36042840

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání